Antibiotic and alpha-blocker found ineffective for chronic prostatitis
A commonly prescribed antibiotic and alpha-blockerappear to be ineffective in the treatment of men with moderate to severechronic prostatitis/chronic pelvic pain syndrome of long duration. Bothciprofloxacin and tamsulosin-used primarily in the treatment of UTI andBPH, respectively-offered no significant benefit in the treatment of chronicprostatitis in patients who were heavily pretreated and had long-standingsymptoms, a multicenter study shows.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.